H.R. 675 (119th)Bill Overview

Domestic SUPPLY Act of 2025

Health|Buy American requirementsCardiovascular and respiratory health
Cosponsors
Support
Republican
Introduced
Jan 23, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Oversight and Government Reform, for a period to be subsequently determined by the Speaker, i…

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill directs HHS, with ASPR and CDC and in coordination with DOD and DHS, to create partnerships with eligible domestic manufacturers to guarantee availability of qualified personal protective equipment (PPE) for public health emergencies. It requires the Secretary to finalize contractual purchasing agreements within one year, defines eligibility criteria for domestic manufacturers (including phased domestic production percentages and majority U.S. ownership), and sets product quality and pricing requirements.

Why people may split

Cost versus security: liberals emphasize safety, conservatives emphasize cost

Watch point

Relative to its intended legislative type, this bill establishes a substantive policy framework for a domestic PPE production partnership program with a complementary procurement restriction and a congressionally mandated report.

This bill directs HHS, with ASPR and CDC and in coordination with DOD and DHS, to create partnerships with eligible domestic manufacturers to guarantee availability of qualified personal protective equipment (PPE) for public health emergencies.

It requires the Secretary to finalize contractual purchasing agreements within one year, defines eligibility criteria for domestic manufacturers (including phased domestic production percentages and majority U.S. ownership), and sets product quality and pricing requirements.

The bill bars federal, state, and local agencies from using federal funds to buy infectious-disease PPE made outside the United States, with certain statutory exceptions and required documentation for exceptions.

Passage40/100

Moderately scoped, bipartisan-appealing subject but contains protectionist mandates and unspecified funding that raise cost, legal, and Senate passage hurdles.

CredibilityPartially aligned

Relative to its intended legislative type, this bill establishes a substantive policy framework for a domestic PPE production partnership program with a complementary procurement restriction and a congressionally mandated report. It defines roles, high‑level mechanisms, eligibility standards, and product qualification criteria, and it anchors provisions to existing statutes and standards.

Contention55/100

Cost versus security: liberals emphasize safety, conservatives emphasize cost

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedManufacturers · Cities

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitStrengthens supply chain resilience and reduces reliance on foreign PPE suppliers.
  • Potential benefitGuarantees government access to specified PPE during declared public health emergencies.
  • Potential benefitEncourages higher quality standards by requiring CDC/OSHA compliance and 510(k) clearance.
Likely burdened
  • Potential burdenMay raise procurement costs if domestic prices exceed prior foreign-sourced PPE.
  • ManufacturersCould reduce competition and limit supplier diversity by excluding foreign manufacturers.
  • CitiesMight strain domestic capacity short-term, causing supply shortages during demand spikes.
03 · Why people split

Why the argument around this bill splits.

Cost versus security: liberals emphasize safety, conservatives emphasize cost
Progressive75%

Generally supportive of strengthening domestic PPE capacity and protecting frontline workers.

Concerned about cost, equitable labor standards, and potential exclusion of global suppliers that could limit access during shortages.

Notes need for clarity on regulatory fit (e.g., NIOSH vs.

Leans supportive
Centrist65%

Cautiously supportive of bolstering domestic supply chains while seeking cost controls and implementation clarity.

Wants oversight on pricing, realistic timelines, and legally sound exception processes to avoid response gaps.

Split reaction
Conservative40%

Mixed reaction: favors domestic manufacturing and national security, but wary of Buy‑American mandates and expanded federal contracting power.

Concerned about market distortions, higher taxpayer costs, and potential corporate favoritism from guaranteed purchases.

Split reaction
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood40/100

Moderately scoped, bipartisan-appealing subject but contains protectionist mandates and unspecified funding that raise cost, legal, and Senate passage hurdles.

Scope and complexity
52%
Scopemoderate
24%
Complexitylow
Why this could stall
  • No cost estimate or dedicated funding provided
  • Feasibility of 100% domestic supply by 2028
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Cost versus security: liberals emphasize safety, conservatives emphasize cost

Moderately scoped, bipartisan-appealing subject but contains protectionist mandates and unspecified funding that raise cost, legal, and Sen…

Unlocked analysis

Relative to its intended legislative type, this bill establishes a substantive policy framework for a domestic PPE production partnership program with a complementary procurement restriction and a congressionally mandat…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis